{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Another Outcome of the COVID-19 Pandemic: The Possible Repurposing of Selective Serotonin Reuptake Inhibitors

Activity Steps

1 Activity
2 Take Test 3Certificate

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the mechanisms that suggest that selective serotonin reuptake inhibitors can be effective in reducing the progression of COVID-19.
  2. Select the results of studies that demonstrated a therapeutic association between selective serotonin reuptake inhibitors and COVID-19.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of the possible use of selective serotonin reuptake inhibitors in reducing symptoms of and mortality from COVID-19 by achieving a minimum score of 70%on the outcomes-based posttest.

Disclosures

The author and planners have disclosed no potential conflicts of interest, financial or otherwise.

Price: $21.95

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Planner
Test Code: CNS0922
Published: Sep/Oct 2022
Expires: 9/6/2024
Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Required Passing Score: 8/10 (80%)
Authors: Patricia Anne O'Malley, PhD, APRN-CNS
Categories: Research
Specialties: Advanced Practice Nursing, Research
Topics: Selective Serotonin Reuptake Inhibitor (SSRI)